Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Autolus Therapeutics PLC Sponsored ADR (AUTL) had Return on Investments of -161.42% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$75.39M |
|
$-287.53M |
|
$96.37M |
|
$-20.98M |
|
$345.93M |
|
$-270.54M |
|
$-15.01M |
|
$-285.56M |
|
$-285.56M |
|
$-287.53M |
|
$-287.53M |
|
$-287.53M |
|
$-287.53M |
|
$-270.54M |
|
$-260.73M |
|
266.14M |
|
266.14M |
|
$-1.08 |
|
$-1.08 |
|
| Balance Sheet Financials | |
$435.92M |
|
$63.56M |
|
$153.15M |
|
$589.07M |
|
$73.44M |
|
-- |
|
$337.50M |
|
$410.94M |
|
$178.13M |
|
$158.32M |
|
$178.13M |
|
266.14M |
|
| Cash Flow Statement Financials | |
$-283.57M |
|
$158.46M |
|
$-4.34M |
|
$228.81M |
|
$105.64M |
|
$-123.17M |
|
$14.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.83% |
|
-358.87% |
|
-358.87% |
|
-345.85% |
|
-378.78% |
|
-381.40% |
|
$-302.61M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
2.90 |
|
3.14 |
|
116.32 |
|
-161.42% |
|
-181.61% |
|
-48.81% |
|
|
Return on Investments |
-161.42% |
$0.67 |
|
$-1.14 |
|
$-1.07 |
|